What this methodology covers
The site publishes structured guidance on eight donor egg IVF destinations. This page explains the editorial logic behind that guidance: what research informs it, how different types of information are treated, and where interpretation comes in.
Why these eight destinations are covered, and what defines the site's scope.
How country facts, legal frameworks, and access rules are researched and checked for consistency.
How editorial cost ranges are built, what they include, and what they leave out.
How structural legal facts are separated from clinic-level variation and market realities.
How shortlist-fit judgments and trade-off framing are kept separate from harder facts.
How the site handles information that varies by clinic, patient profile, or practical circumstance.
What the site covers
Fertility Decision covers IVF with donor eggs abroad. Coverage is deliberately bounded: the site covers eight destinations selected to support realistic comparison, not to catalogue every possible option globally.
Those eight destinations are:
- Spain
- Czech Republic
- Greece
- Portugal
- North Cyprus
- Denmark
- United Kingdom
- South Africa
Country coverage is deliberately bounded. The goal is a useful set for realistic comparison, not a comprehensive global directory.
How countries were selected
These eight destinations were selected because they represent meaningful decision options for the site's primary audience: people considering donor egg IVF abroad who are trying to narrow a realistic shortlist.
The covered set spans a meaningful range across five decision dimensions:
Anonymous-only, identifiable-only, and donor-choice frameworks are all represented.
Limits range from around 46 at the most restrictive to above 54 at the most permissive.
Most destinations accept single women. Some are restricted to couples only.
From the most affordable European options through to higher-cost regulated markets.
Includes EU-regulated markets and destinations operating outside that framework.
Coverage is deliberately selective. A destination is included when it changes what users can realistically compare, not simply to expand the list.
How information is researched and checked
Country guidance is built from a combination of legal and regulatory sources, structured research into clinic practices, and editorial review for internal consistency across the site.
Age limits, donor anonymity rules, and single women access are verified against national law and regulatory authority guidance. These are treated as structural facts, subject to the caveat that legal access and practical access can differ.
Pricing structures, cycle models, donor matching approaches, and visit requirements are researched through structured review of clinic-level information. The site looks for repeatable country-level patterns rather than relying on individual clinic marketing claims.
The site also draws on structured research into how clinics across the covered countries report success rates, present pricing, and describe donor matching. Where these vary systematically by country, that shapes how the site caveats and interprets country-level figures.
Supporting references are listed separately on the sources page, rather than repeated here.
How cost estimates are handled
Cost ranges on the site are editorial estimates designed for comparing destinations, not for budgeting a specific treatment cycle.
What the base estimate reflects
- The base clinic package price as publicly advertised
- The dominant cycle model in that country's market
- The figure a patient is likely to see first when reviewing a price list or making an initial inquiry
What it usually excludes
- Recipient medication, a separate line item at almost all clinics
- Travel, accommodation, and return trips
- Mandatory screening tests billed before treatment
- Embryo freezing and storage
- Optional add-ons such as PGT-A or assisted hatching
The estimate reflects the dominant market model in each country rather than forcing one identical pricing frame across all destinations. A market where fresh donor cycles are the primary published model is treated differently from one built primarily around banked donor eggs.
Pricing estimates are informed by structured research into clinic pricing across the covered countries, then normalized into editorial ranges for decision-support use. These are not verified national averages and should not be read as guaranteed prices.
The key comparison insight: treatment choices and add-ons often change the final total more than country choice alone. Cost ranges are most useful for identifying whether a destination is broadly realistic for a given budget.
How law, practice, and clinic-level variation are treated
Country guidance distinguishes three layers of information, because they carry different levels of certainty and stability.
Legal framework and access rules
Donor anonymity requirements, national age limits, and single women access rights are defined by law. These change slowly and are the most reliable cross-country comparison points. Even here, some countries set limits by law while others apply them through clinical practice rather than legislation.
Cycle models and pricing patterns
Whether clinics in a country predominantly run synchronized fresh donor cycles or use banked frozen egg inventories is a market-level pattern. These are observable and useful for comparison, but they are not fixed rules, and transition periods are common.
Matching, timing, and practical availability
Donor availability, matching approaches, and waiting times are determined at clinic level, not nationally. Some legal possibilities exist on paper but are limited or inconsistent in practice. Where this is the case, the site uses qualified language rather than presenting a clean national fact.
Practical interpretation across all three layers draws on research into donor matching models, pricing structures, success-rate transparency, and visit requirements across the covered countries.
How editorial judgments are made
The site does not only repeat facts. It also interprets them to help users decide, using a clear and consistent editorial logic.
Country fit
Which countries are stronger or weaker fits for a specific constraint, such as age or donor type.
Trade-off framing
What trade-offs define a destination and for whom those trade-offs are acceptable.
Shortlist elimination
Which options a given constraint removes from the shortlist entirely.
Practical weight
Where legal or market differences matter more or less in practice.
The goal is to reduce wrong-fit options earlier, not to flatten every destination into a neutral summary. Where a country is clearly weaker for a particular user type, the site says so. Structural facts and editorial interpretation are kept separate as much as possible, so users can tell the difference between a hard constraint and a judgment call.
What this methodology does not guarantee
- Treatment access at any specific clinic. Country coverage does not guarantee that any particular clinic will accept a patient, confirm availability, or offer the treatment described.
- Exact treatment cost. Cost ranges are editorial estimates for decision-support use, not verified national averages or guaranteed prices.
- Medical advice. Country guidance does not replace a discussion with a fertility specialist or a consultation with a treating clinic.
- Fixed practical details across a whole country. Donor availability, matching timelines, and clinical protocols vary by clinic even within the same country.
- That every detail stays current. Country information reflects the state at the time of research. Laws, regulations, and clinical practices can change, and some details may become outdated before they are reviewed.